Rozita Bagheri-Yarmand

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Induced Apoptosis

Heat Shock Protein

Tyrosine Kinase

Multiple Myeloma

Top Venues

Molecular cancer research : MCR

Nature communications

Molecular cancer therapeutics

The University of Texas MD Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas MD Anderson Cancer Center Sep 13 1999

United States

Assistant Professor :: Endocrine Neoplasia & HD

Publications

Huan Liu, Jin He, Rozita Bagheri-Yarmand, Zongwei Li, Rui Liu, Zhiming Wang, Duc-Hiep Bach, Yung-Hsing Huang, Pei Lin, Theresa A Guise, Robert F Gagel, Jing Yang
Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. Nature communications 13 (1) (2022)
Rozita Bagheri-Yarmand, Ramona Dadu, Lei Ye, Yaashmin Shiny Jebaraj, Jade A Martinez, Junsheng Ma, Rohinton S Tarapore, Joshua E Allen, Steven I Sherman, Michelle D Williams, Robert F Gagel
ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2. Molecular cancer therapeutics 20 (4) (2021)
Rozita Bagheri-Yarmand, Krishna M Sinha, Ling Li, Yue Lu, Gilbert J Cote, Steven I Sherman, Robert F Gagel
Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. Molecular cancer research : MCR 17 (3) (2018)